May 13, 2020
QurAlis raises $42 million to chase therapies for amyotrophic lateral sclerosis (ALS)
QurAlis has raised $42 million in Series A funding to develop new therapies for amyotrophic lateral sclerosis (ALS).
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Quralis